WO2023020501A1 - Method for extracting fr901464 from burkholderia fermentation broth - Google Patents
Method for extracting fr901464 from burkholderia fermentation broth Download PDFInfo
- Publication number
- WO2023020501A1 WO2023020501A1 PCT/CN2022/112833 CN2022112833W WO2023020501A1 WO 2023020501 A1 WO2023020501 A1 WO 2023020501A1 CN 2022112833 W CN2022112833 W CN 2022112833W WO 2023020501 A1 WO2023020501 A1 WO 2023020501A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eluent
- ethyl acetate
- fermentation broth
- acetonitrile
- silica gel
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 29
- 230000004151 fermentation Effects 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 25
- 241001453380 Burkholderia Species 0.000 title claims abstract description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 81
- 239000007788 liquid Substances 0.000 claims abstract description 32
- 239000003480 eluent Substances 0.000 claims abstract description 29
- PJKVJJDQXZARCA-QHYZBLTGSA-N FR901464 Chemical compound O1[C@H](C)[C@H](NC(=O)\C=C/[C@@H](OC(C)=O)C)C[C@H](C)[C@@H]1C\C=C(/C)\C=C\[C@@H]1[C@@H](O)[C@@]2(OC2)C[C@@](C)(O)O1 PJKVJJDQXZARCA-QHYZBLTGSA-N 0.000 claims abstract description 25
- 239000011347 resin Substances 0.000 claims abstract description 24
- 229920005989 resin Polymers 0.000 claims abstract description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000741 silica gel Substances 0.000 claims abstract description 18
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 18
- 239000012046 mixed solvent Substances 0.000 claims abstract description 12
- 239000003960 organic solvent Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 63
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 238000012856 packing Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000012454 non-polar solvent Substances 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 239000000945 filler Substances 0.000 abstract description 22
- 239000012074 organic phase Substances 0.000 abstract description 18
- 239000000843 powder Substances 0.000 abstract description 13
- 238000001179 sorption measurement Methods 0.000 abstract description 7
- 239000007787 solid Substances 0.000 abstract description 6
- 238000010828 elution Methods 0.000 abstract description 4
- 238000013375 chromatographic separation Methods 0.000 abstract description 2
- 239000007791 liquid phase Substances 0.000 abstract description 2
- 238000002791 soaking Methods 0.000 abstract description 2
- 238000001704 evaporation Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 description 15
- 238000000746 purification Methods 0.000 description 14
- 235000010633 broth Nutrition 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000002386 leaching Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 3
- 241001508395 Burkholderia sp. Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000589774 Pseudomonas sp. Species 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004262 preparative liquid chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- FR901464 is a natural compound with high anti-tumor activity. It was originally isolated and purified from Pseudomonas sp. by fermentation in 1996 by Nakajima et al. (Nakajima, H.; Sato, B.; Fujita, T. ; Takase, S.; Terano, H.; Okuhara, M.Antitumor substances, FR901463, FR901464 and FR901465.I.
- Step 3 dissolving the product concentrated in step 2 with a mixed solvent, separating and filtering in a silica gel column, and rinsing with eluent A to obtain an eluent;
- the polar solvent is selected from alcohols, acids, fats, nitriles, water, preferably isopropanol, n-butanol, tetrahydrofuran, chloroform, ethanol, ethyl acetate, methanol, acetone, acetonitrile, acetic acid , more preferably ethyl acetate;
- the non-polar solvent is selected from saturated hydrocarbons, benzene, preferably n-hexane.
- the collected organic phase is dehydrated with anhydrous magnesium sulfate, filtered and then evaporated to dryness to form a solid powder.
- Adsorption rate (%) 100% - supernatant titer/fermentation pot titer * 100%
- Example 3 the paste was dissolved in a mixed solvent of n-hexane:ethyl acetate (v:v) of 50:50, filtered and then chromatographically separated with a silica gel filler, and then the FR901464 adsorbed on the silica gel was separated with ethyl acetate Eluted off, while more polar impurities and pigments are adsorbed on silica gel.
- the purity of FR901464 in the eluent was measured by the peak area distribution of HPLC (ie the peak area of FR901464 accounted for the percentage of the total peak area, the purity in the following examples were all obtained by this method), and the result was 58.25%.
- Step 5 Step 4 was repeated to obtain an eluate with a purity of 68.68%.
- the eluate was concentrated by a rotary evaporator at 40° C., and the eluate was concentrated to a paste.
- Step 6 The above paste was prepared as a column liquid with 30% volume concentration of acetonitrile.
- the upper column liquid is separated and purified by high-pressure liquid chromatography, and the filler is Kromasil C18 filler. Elution with 40% volume concentration of acetonitrile in water gave a purity of 95.68%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Provided in the present invention is a method for extracting FR901464 from a fermentation broth. The fermentation broth is obtained by means of fermenting Burkholderia. A fermentation method comprises: adding a macroporous resin to the fermentation broth, and subjecting the mixture to adsorption and then filtration; soaking and separating the filtered macroporous resin with an organic solvent, and concentrating the separated organic solvent; dissolving the concentrated product with a mixed solvent of n-hexane and ethyl acetate, performing chromatographic separation by means of silica gel, and then performing elution with ethyl acetate to obtain an eluent; concentrating the eluent into a paste, and then formulating same into a column loading solution which is separated and purified by means of a high-pressure liquid chromatograph, wherein the filler is a C18 filler, and performing elution with a liquid-phase eluent to obtain an eluent; and extracting the eluent and then collecting an organic phase, and evaporating same until dry to form a solid powder.
Description
本发明涉及发酵液纯化技术领域,具体涉及一种从伯克霍尔德菌发酵液提取FR901464的方法。The invention relates to the technical field of fermentation broth purification, in particular to a method for extracting FR901464 from Burkholderia fermentation broth.
FR901464是一种具有高效抗肿瘤活性的天然化合物,最初由Nakajima等人于1996年通过发酵从假单孢菌Pseudomonas sp.中分离纯化得到(Nakajima,H.;Sato,B.;Fujita,T.;Takase,S.;Terano,H.;Okuhara,M.Antitumor substances,FR901463,FR901464 and FR901465.I.taxonomy,fermentation,isolation,physico-chemical properties and biological activities[J].J.Antibiot.,1996,49:1196-1203.),其中,文中所述的假单孢菌Pseudomonas sp.No.2663发酵产量约360mg/L。其化学结构式如式1所示。FR901464 is a natural compound with high anti-tumor activity. It was originally isolated and purified from Pseudomonas sp. by fermentation in 1996 by Nakajima et al. (Nakajima, H.; Sato, B.; Fujita, T. ; Takase, S.; Terano, H.; Okuhara, M.Antitumor substances, FR901463, FR901464 and FR901465.I. taxonomy, fermentation, isolation, physico-chemical properties and biological activities[J].J.Antibiot.,1996, 49:1196-1203.), wherein, the Pseudomonas sp.No.2663 fermentation output described in the text is about 360mg/L. Its chemical structural formula is shown in Formula 1.
作为真核细胞中前体mRNA的剪接抑制剂,FR901464对肿瘤细胞生长有很强的抑制作用,活性测试表明,FR901464对人类实体肿瘤细胞产生了十分显著的抑制作用,实验测试得IC50值在0.3-3.4nM。由于FR901464在抗肿瘤方面表现了极高的活性,且其生理活性独特,刚发现就引起了科学家们的广泛关注。As a splicing inhibitor of precursor mRNA in eukaryotic cells, FR901464 has a strong inhibitory effect on the growth of tumor cells. Activity tests show that FR901464 has a very significant inhibitory effect on human solid tumor cells. The IC50 value of the experimental test is 0.3 -3.4nM. Because FR901464 exhibits extremely high anti-tumor activity and its unique physiological activity, it has attracted widespread attention from scientists as soon as it was discovered.
Nakajima H等虽然在《New antitumor substances,FR901463,FR901464 and FR901465 I.Taxonomy,fermentation,isolation,physico-chemical properties and biological activities》中公开了提纯方法,该方法需要消耗大量的乙酸乙酯进行提取,并且经申请人尝试并不能获得高纯度的FR901464。Although Nakajima H etc. disclosed the purification method in "New antitumor substances, FR901463, FR901464 and FR901465 I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities", this method needs to consume a large amount of ethyl acetate for extraction, and High purity FR901464 could not be obtained through the applicant's attempts.
发明内容Contents of the invention
为了克服上述问题,本发明提供了一种从发酵液提取FR901464的方法,其特征在于:In order to overcome the above problems, the present invention provides a method for extracting FR901464 from fermentation broth, characterized in that:
所述发酵液由伯克霍尔德菌发酵得到,提取方法包括以下步骤:The fermented liquid is fermented by Burkholderia, and the extraction method comprises the following steps:
步骤1:将大孔树脂加入发酵液,混合吸附后过滤;Step 1: Add the macroporous resin to the fermentation broth, mix and absorb and filter;
步骤2:将过滤得到的大孔树脂用有机溶剂浸泡并分离,将分离后的有机溶剂浓缩;Step 2: Soak and separate the macroporous resin obtained by filtration with an organic solvent, and concentrate the separated organic solvent;
步骤3:用混合溶剂溶解步骤2浓缩后的产物,在硅胶柱中分离过滤,经洗脱剂A淋洗得到洗脱液;Step 3: dissolving the product concentrated in step 2 with a mixed solvent, separating and filtering in a silica gel column, and rinsing with eluent A to obtain an eluent;
步骤4:浓缩洗脱液至膏状,随后配制成上柱液,并用洗脱剂B经高压液相色谱仪分离纯化。Step 4: Concentrate the eluate to a creamy state, and then make it into a column liquid, and use eluent B to separate and purify by high-pressure liquid chromatography.
优选地,在步骤4后面为步骤5:步骤4中的洗脱液经萃取后收集有机相,蒸干后形成固体粉末。Preferably, step 4 is followed by step 5: the eluate in step 4 is extracted and the organic phase is collected and evaporated to dryness to form a solid powder.
优选地,高压液相色谱仪的填料为C18填料。Preferably, the packing of the high pressure liquid chromatograph is C18 packing.
优选地,步骤1中,将大孔树脂加入发酵液后搅拌。Preferably, in step 1, the macroporous resin is added to the fermentation broth and then stirred.
优选地,步骤1中,吸附时间不低于3h,或4h。Preferably, in step 1, the adsorption time is not less than 3h, or 4h.
优选地,步骤2中,浸泡时间不低于1h,或2h。Preferably, in step 2, the soaking time is not less than 1h, or 2h.
优选地,步骤2中,大孔树脂分别用有机溶剂浸泡2次或更多。Preferably, in step 2, the macroporous resin is soaked with organic solvent twice or more.
优选地,所述混合溶剂由极性溶剂和非极性溶剂混合而成。Preferably, the mixed solvent is formed by mixing a polar solvent and a non-polar solvent.
优选地,所述极性溶剂选自醇、酸、脂、腈、水,优选地选自为异丙醇、正丁醇、四氢呋喃、氯仿、乙醇、乙酸乙酯、甲醇、丙酮、乙腈、乙酸,更优选地为乙酸乙酯;所述非极性溶剂选自饱和烃类、苯,优选地为正己烷。Preferably, the polar solvent is selected from alcohols, acids, fats, nitriles, water, preferably isopropanol, n-butanol, tetrahydrofuran, chloroform, ethanol, ethyl acetate, methanol, acetone, acetonitrile, acetic acid , more preferably ethyl acetate; the non-polar solvent is selected from saturated hydrocarbons, benzene, preferably n-hexane.
优选地,正己烷与乙酸乙酯混合形成所述混合溶剂,其中乙酸乙酯的体积分数不大于70%。Preferably, n-hexane and ethyl acetate are mixed to form the mixed solvent, wherein the volume fraction of ethyl acetate is not greater than 70%.
优选地,步骤4中,用30%体积分数的乙腈配制成上柱液。Preferably, in step 4, the upper column solution is prepared with 30% volume fraction of acetonitrile.
优选地,步骤2中的有机溶剂选自乙酸乙酯、二氯甲烷、氯仿。Preferably, the organic solvent in step 2 is selected from ethyl acetate, dichloromethane, and chloroform.
优选地,洗脱剂A为乙酸乙酯,洗脱剂B选自乙腈或甲醇的水溶液。Preferably, the eluent A is ethyl acetate, and the eluent B is selected from acetonitrile or methanol in water.
优选地,洗脱剂B为乙腈溶液,体积浓度为30%-45%,或者为30%-40%。Preferably, the eluent B is an acetonitrile solution with a volume concentration of 30%-45%, or 30%-40%.
优选地,步骤3和步骤4之间包括步骤3.1:将步骤3得到的洗脱液浓缩至膏状,重复步骤3得到洗脱液。Preferably, step 3.1 is included between step 3 and step 4: concentrate the eluate obtained in step 3 to a paste, and repeat step 3 to obtain the eluate.
优选地,硅胶柱中硅胶填料规格为100-200目,孔径
Preferably, the specification of the silica gel filler in the silica gel column is 100-200 mesh, and the pore diameter is
优选地,步骤4中,上柱液在高压液相色谱仪中的流速为50-70ml/min,优选70ml/min。Preferably, in step 4, the flow rate of the upper column liquid in the high pressure liquid chromatograph is 50-70ml/min, preferably 70ml/min.
优选地,步骤5中,收集的有机相经过无水硫酸镁脱水处理,过滤后蒸干形成固体粉末。Preferably, in step 5, the collected organic phase is dehydrated with anhydrous magnesium sulfate, filtered and then evaporated to dryness to form a solid powder.
本发明适用于市面上可获得的任何一种伯克霍尔德菌发酵得到的发酵液,优选地,所述伯克霍尔德菌为伯克霍尔德菌(Burkholderia sp.)HDCC00024,保藏于中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),保藏编号为CGMCC NO.22290,保藏日期为2021年05月08日。The present invention is applicable to the fermentation broth obtained by fermentation of any Burkholderia sp. available on the market, preferably, the Burkholderia sp. HDCC00024, preserved In the General Microorganism Center (CGMCC) of the China Committee for the Collection of Microorganisms, the preservation number is CGMCC NO.22290, and the preservation date is May 08, 2021.
1、采用本发明的提纯方法,最终产物中FR901464的纯度高;1. By adopting the purification method of the present invention, the purity of FR901464 in the final product is high;
2、本发明的提纯方法的操作步骤简单。适合工业化生产;2. The operation steps of the purification method of the present invention are simple. Suitable for industrial production;
3、利用高压制备液相色谱仪以及特定溶剂和浓度的流动相能够有效地除去结构相似、难以分离的FR901464类似物;3. Using high-pressure preparative liquid chromatography and mobile phase with specific solvent and concentration can effectively remove FR901464 analogues with similar structures and difficult to separate;
4、通过硅胶填料可以除去大部分极性较大的以及色素类杂质。4. Most of the more polar and pigment impurities can be removed through the silica gel filler.
图1为发酵液的液相色谱图;Fig. 1 is the liquid chromatogram of fermented liquid;
图2为实施例8中FR901464成品粉末液相图谱。Fig. 2 is the liquid chromatogram of finished powder of FR901464 in embodiment 8.
下述实施例中所用的实验方法如无特殊说明,均为常规方法。The experimental methods used in the following examples are conventional methods unless otherwise specified.
下述实施例中采用的材料、试剂等如无特殊说明,皆为普通市售品,皆可于市场购得。Unless otherwise specified, the materials and reagents used in the following examples are commercially available and can be purchased in the market.
下面将通过实施例对本发明作进一步的描述,这些描述并不是对本发明内容作进一步的限定。本领域的技术人员应理解,对本发明内容所作的等同替换,或相应的改进,仍属于本发明的保护范围之内。The present invention will be further described through examples below, and these descriptions are not intended to further limit the content of the present invention. Those skilled in the art should understand that equivalent replacements or corresponding improvements made to the contents of the present invention still fall within the protection scope of the present invention.
提纯中所使用的乙腈、乙酸乙酯、二氯甲烷、氯仿、正己烷、甲醇的纯度为工业级。The purity of acetonitrile, ethyl acetate, dichloromethane, chloroform, n-hexane and methanol used in the purification is industrial grade.
以下实施例所涉及的发酵液根据申请号为CN202110681279.4的专利申请得到,采用的菌株为伯克霍尔德菌(Burkholderia sp.)HDCC00024(CGMCC NO.22290)。具体发酵方法为:The fermentation broth involved in the following examples was obtained according to the patent application with the application number CN202110681279.4, and the strain used was Burkholderia sp. HDCC00024 (CGMCC NO.22290). The specific fermentation method is:
(1)斜面菌种的制备与培养:(1) Preparation and cultivation of slant strains:
斜面培养基配方(g/L):酵母抽提粉4.0g/L,麦芽抽提物10.0g/L,葡萄糖4.0g/L,琼脂20.0g/L,消前pH 7.2~7.4,试管30×200mm,装量15mL,经121℃灭菌20min,冷却至55-60℃左右摆斜面,待冷却凝固后,接种至斜面,28±1℃培养3天后,菌种成熟。Slant medium formula (g/L): yeast extract powder 4.0g/L, malt extract 10.0g/L, glucose 4.0g/L, agar 20.0g/L, pH before elimination 7.2~7.4, test tube 30× 200mm, filling volume 15mL, sterilized at 121°C for 20 minutes, cooled to about 55-60°C and placed on a slope, after cooling and solidification, inoculated on the slope, cultivated at 28±1°C for 3 days, the strains matured.
(2)种子液的制备与培养:(2) Preparation and cultivation of seed solution:
种子培养基配方(g/L):葡萄糖30g/L、山梨醇5g/L、棉籽饼粉10g/L、酵母抽提粉20g/L、氯化钙10g/L,硫酸镁10g/L,磷酸二氢钾1g/L,消前pH 7.0;250mL规格的三角摇瓶,装量50mL,121℃灭菌20min。接种10
7~10
8cfu/mL至种子培养基中,28±1℃,250rpm振荡培养24小时,此时培养液pH 6.8-7.2,菌体OD600为15-20。
Seed medium formula (g/L): glucose 30g/L, sorbitol 5g/L, cottonseed cake powder 10g/L, yeast extract powder 20g/L, calcium chloride 10g/L, magnesium sulfate 10g/L, phosphoric acid Potassium dihydrogen 1g/L, pH 7.0 before disinfection; 250mL Erlenmeyer shaker flask, filled with 50mL, sterilized at 121°C for 20min. Inoculate 10 7 ~10 8 cfu/mL into the seed medium, culture at 28±1°C, shake at 250 rpm for 24 hours, at this time, the pH of the culture solution is 6.8-7.2, and the OD600 of the bacteria is 15-20.
(3)发酵培养基的制备与培养:(3) Preparation and cultivation of fermentation medium:
玉米淀粉20g/L、葡萄糖30g/L、山梨醇10g/L、甘露醇10g/L、酵母抽提粉6g/L、黄 豆饼粉8g/L、棉籽饼粉7g/L、硫酸镁3g/L、磷酸二氢钾6g/L、氯化钾3g/L、氯化钙3g/L。消前pH 6.0。250mL规格的三角摇瓶,装量20mL,121℃灭菌20min。将种子液以10%(体积比)的接种量接入。在26±1℃,250rpm振荡培养96小时。Corn starch 20g/L, glucose 30g/L, sorbitol 10g/L, mannitol 10g/L, yeast extract powder 6g/L, soybean cake powder 8g/L, cottonseed cake powder 7g/L, magnesium sulfate 3g/L , Potassium dihydrogen phosphate 6g/L, potassium chloride 3g/L, calcium chloride 3g/L. The pH before disinfection is 6.0. A 250mL Erlenmeyer shaker flask should contain 20mL and be sterilized at 121°C for 20min. The seed solution was added with an inoculation amount of 10% (volume ratio). Culture at 26±1° C. with shaking at 250 rpm for 96 hours.
实施例1大孔树脂吸附Embodiment 1 macroporous resin adsorption
取四组发酵液,分别按照下表加入不同规格的大孔树脂,经搅拌吸附后,取发酵上清液,经HPLC方法检测上清液中FR901464的效价。Take four groups of fermentation broths, add macroporous resins of different specifications according to the following table respectively, after stirring and absorbing, take the fermentation supernatant, and detect the titer of FR901464 in the supernatant by HPLC method.
吸附率(%)=100%-上清液效价/发酵放罐效价*100%Adsorption rate (%) = 100% - supernatant titer/fermentation pot titer * 100%
实施例2溶剂浸提Embodiment 2 solvent extraction
按照上述实施例1中第1组的吸附方式得到发酵液和大孔树脂LX-30的混合物,通过振荡筛分离得到大孔树脂LX-30,按照下表的方式将浸提溶剂加入大孔树脂LX-30中搅拌2h后分离收集浸提液。通过HPLC检测浸提液中FR901464的效价。Obtain the mixture of fermented liquid and macroporous resin LX-30 according to the adsorption method of the first group in the above-mentioned Example 1, and obtain the macroporous resin LX-30 through vibrating sieve separation, and add the extraction solvent to the macroporous resin according to the following table After stirring in LX-30 for 2h, separate and collect the extract. The potency of FR901464 in the extract was detected by HPLC.
浸提收率=浸提液效价*浸提液体积/(树脂重量*树脂效价)*100%Extraction yield = extraction solution titer * extraction solution volume / (resin weight * resin titer) * 100%
实施例3硅胶分离Embodiment 3 Silica gel separation
参照实施例2,在1.27kg吸附后的大孔树脂LX-30中,加入2.5L的乙酸乙酯浸提,搅拌2h后分离浸提液,共浸提两次,得到混合浸提液4.7L,静置分液后分离得到有机相4.5L。在40℃条件下,将有机相通过旋转蒸发器浓缩至膏状。Referring to Example 2, in 1.27 kg of adsorbed macroporous resin LX-30, 2.5 L of ethyl acetate was added for extraction, after stirring for 2 hours, the extraction solution was separated, and the extraction solution was co-extracted twice to obtain 4.7 L of mixed extraction solution. , after standing still for liquid separation, 4.5 L of organic phase was obtained. At 40 °C, the organic phase was concentrated to a paste by a rotary evaporator.
取上述膏状物,分别按照下表的正己烷与乙酸乙酯混合溶剂溶解并过滤,将膏状物用混合溶剂配制成3g/L左右,溶液用硅胶填料(100-200目,孔径
)进行色谱分离。
Take the above-mentioned paste, dissolve and filter according to the mixed solvent of n-hexane and ethyl acetate in the following table, and prepare the paste with a mixed solvent to about 3g/L. The solution is filled with silica gel (100-200 mesh, pore size ) for chromatographic separation.
正己烷:乙酸乙酯(v:v)n-Hexane: ethyl acetate (v:v) | 吸附率(%)Adsorption rate(%) |
30:7030:70 | 98.998.9 |
40:6040:60 | 100100 |
50:5050:50 | 100100 |
结果表明,层析过程中,当上柱液中乙酸乙酯比例升高,硅胶吸附率下降,当比例为30:70时,上柱过滤中有FR901464漏出。The results showed that during the chromatography process, when the ratio of ethyl acetate in the upper column solution increased, the silica gel adsorption rate decreased. When the ratio was 30:70, FR901464 leaked out from the upper column filtration.
通过该步骤,极性小的杂质随液体流出,FR901464及极性大的物质会吸附在硅胶中。Through this step, the less polar impurities flow out with the liquid, and FR901464 and more polar substances will be adsorbed in the silica gel.
实施例4硅胶分离Embodiment 4 Silica gel separation
参照实施例3,用正己烷:乙酸乙酯(v:v)为50:50的混合溶剂溶解膏状物,过滤后用硅胶填料进行色谱分离,随后用乙酸乙酯将吸附在硅胶上的FR901464洗脱下来,而极性更大的杂质以及色素则吸附在硅胶上。通过HPLC的峰面积分布测量洗脱液中FR901464的纯度(即FR901464的峰面积占总峰面积的百分比,以下实施例中的纯度均通过该方法获得),结果为58.25%。洗脱液在40℃条件下,通过旋转蒸发器浓缩至膏状。重复上述步骤,得到纯度为75.68%的洗脱液,并浓缩至膏状,用30%体积分数的乙腈配制成上柱液。Referring to Example 3, the paste was dissolved in a mixed solvent of n-hexane:ethyl acetate (v:v) of 50:50, filtered and then chromatographically separated with a silica gel filler, and then the FR901464 adsorbed on the silica gel was separated with ethyl acetate Eluted off, while more polar impurities and pigments are adsorbed on silica gel. The purity of FR901464 in the eluent was measured by the peak area distribution of HPLC (ie the peak area of FR901464 accounted for the percentage of the total peak area, the purity in the following examples were all obtained by this method), and the result was 58.25%. The eluate was concentrated to a paste by a rotary evaporator at 40 °C. The above steps were repeated to obtain an eluate with a purity of 75.68%, which was concentrated to a paste and prepared as a column liquid with 30% volume fraction of acetonitrile.
实施例5高压液相色谱仪分离纯化Embodiment 5 High pressure liquid chromatography separation and purification
用实施例4中的上柱液,进行高压液相色谱仪分离纯化,填料为华谱C18填料,液相洗脱剂分别用乙腈和甲醇,洗脱剂中溶剂体积浓度为35%,流速为70ml/min,柱温为室温。实验数据如下表,表中洗脱剂用量为填料体积的倍数。With the upper column liquid in embodiment 4, carry out high-pressure liquid chromatography separation and purification, filler is Huapu C18 filler, and liquid phase eluent uses acetonitrile and methanol respectively, and solvent volume concentration is 35% in the eluent, and flow velocity is 70ml/min, the column temperature is room temperature. The experimental data are shown in the table below, and the amount of eluent in the table is the multiple of the packing volume.
洗脱剂eluent | 合格组份纯度(%)Qualified component purity (%) | 洗脱剂用量(BV)Eluent volume (BV) |
35%乙腈35% acetonitrile | 95.6895.68 | 11 |
35%甲醇35% methanol | 86.3086.30 | 33 |
实施例6高压液相色谱仪分离纯化Embodiment 6 High pressure liquid chromatography separation and purification
用实施例4中的上柱液,进行高压液相色谱仪分离纯化,填料为华谱C18填料,分别用4种不同体积浓度的乙腈作为洗脱剂,流速为70ml/min,柱温为室温。结果表明乙腈浓度30%-40%,效果较好。实验结果如下表:Carry out the separation and purification of high pressure liquid chromatography with the upper column liquid in embodiment 4, filler is Huapu C18 filler, use the acetonitrile of 4 kinds of different volume concentrations respectively as eluent, flow velocity is 70ml/min, and column temperature is room temperature . The results show that the concentration of acetonitrile is 30%-40%, and the effect is better. The experimental results are as follows:
乙腈浓度(%)Acetonitrile concentration (%) | 合格组份纯度(%)Qualified component purity (%) | 收率(%)Yield (%) |
3030 | 97.0897.08 | 74.3474.34 |
3535 | 95.9195.91 | 69.7469.74 |
4040 | 95.4495.44 | 62.7362.73 |
4545 | 92.0192.01 | 40.3640.36 |
实施例7高压液相色谱仪分离纯化Embodiment 7 high pressure liquid chromatograph separation and purification
用实施例4中的上柱液,进行高压液相色谱仪分离纯化,洗脱液为35%乙腈,分别用3种C18填料(纳微C18填料、华谱C18填料、Kromasil C18填料)进行分离纯化实验,流速为70ml/min,柱温为室温,实验结果如下表:Using the upper column liquid in Example 4, carry out separation and purification by high-pressure liquid chromatography, the eluent is 35% acetonitrile, and separate with 3 kinds of C18 fillers (Nanomicro C18 fillers, Huapu C18 fillers, Kromasil C18 fillers) respectively In the purification experiment, the flow rate was 70ml/min, and the column temperature was room temperature. The experimental results are as follows:
填料型号Packing type | 合格组份纯度(%)Qualified component purity (%) | 收率(%)Yield (%) |
纳微C18填料Nano micro C18 filler | 95.5595.55 | 65.8165.81 |
华谱C18填料Huapu C18 filler | 95.9195.91 | 69.7469.74 |
Kromasil C18填料Kromasil C18 filler | 96.0396.03 | 63.1863.18 |
实施例8高压液相色谱仪分离纯化 Embodiment 8 High-pressure liquid chromatograph separation and purification
用实施例4中的上柱液,进行高压液相色谱仪分离纯化,洗脱液为35%乙腈,填料为华谱C18填料,流速为70ml/min,柱温为室温,得到纯度为96.14%的洗脱液。洗脱液用乙酸乙酯进行萃取,静置分液得到有机相。有机相用无水硫酸镁进行脱水、过滤。脱水后的有机相,在40℃条件下,用旋转蒸发器浓缩至固体粉末,纯度为96.75%,总收率为26.6%。Using the upper column liquid in Example 4, carry out separation and purification by high-pressure liquid chromatography, the eluent is 35% acetonitrile, the filler is Huapu C18 filler, the flow rate is 70ml/min, and the column temperature is room temperature to obtain a purity of 96.14%. eluent. The eluent was extracted with ethyl acetate, and the organic phase was obtained by static separation. The organic phase was dehydrated with anhydrous magnesium sulfate and filtered. The dehydrated organic phase was concentrated to a solid powder with a rotary evaporator at 40° C., with a purity of 96.75% and a total yield of 26.6%.
实施例9Example 9
步骤1:取25L的FR901464发酵液,加入2.5kg大孔树脂HP20,搅拌12h后,取样检测发酵液中FR901464含量为11.34ug/ml。然后用振荡筛分离发酵液和大孔树脂,得到2.3kg大孔树脂HP20。Step 1: Take 25L of FR901464 fermentation broth, add 2.5kg of macroporous resin HP20, stir for 12 hours, take a sample and detect that the content of FR901464 in the fermentation broth is 11.34ug/ml. Then separate fermentation broth and macroporous resin with vibrating sieve, obtain 2.3kg macroporous resin HP20.
步骤2:在分离得到的2.3kg大孔树脂HP20中加入4.2L的氯仿浸提,浸提时间4h,浸提两次,得到混合浸提液8.2L。Step 2: Add 4.2 L of chloroform to the separated 2.3 kg macroporous resin HP20 for leaching. The leaching time is 4 hours, and leaching is performed twice to obtain 8.2 L of mixed extracts.
步骤3:混合浸提液静置分液,得到有机相8L。将有机相在40℃条件下,通过旋转蒸发器进行浓缩,将混合浸提液浓缩至膏状。Step 3: The mixed extracts were left to stand for liquid separation to obtain 8 L of organic phase. The organic phase was concentrated by a rotary evaporator at 40° C., and the mixed extract was concentrated to a paste.
步骤4:用正己烷与乙酸乙酯混合溶剂(体积比50:50)溶解膏状物并过滤,滤液用硅胶填料进行色谱分离,得到纯度为57.22%的洗脱液。洗脱液在40℃条件下,通过旋转蒸发器进行浓缩,将洗脱液浓缩至膏状。Step 4: Dissolve the paste with a mixed solvent of n-hexane and ethyl acetate (volume ratio 50:50) and filter. The filtrate is chromatographically separated with a silica gel packing to obtain an eluent with a purity of 57.22%. The eluate was concentrated by a rotary evaporator at 40° C., and the eluate was concentrated to a paste.
步骤5:重复步骤4得到纯度为68.68%的洗脱液。洗脱液在40℃条件下,通过旋转蒸发器进行浓缩,将洗脱液浓缩至膏状。Step 5: Step 4 was repeated to obtain an eluate with a purity of 68.68%. The eluate was concentrated by a rotary evaporator at 40° C., and the eluate was concentrated to a paste.
步骤6:上述膏状物用30%体积浓度的乙腈配制成上柱液。上柱液用高压液相色谱仪进行分离纯化,填料为Kromasil C18填料。用40%体积浓度的乙腈水溶液进行洗脱,得到纯度为95.68%。Step 6: The above paste was prepared as a column liquid with 30% volume concentration of acetonitrile. The upper column liquid is separated and purified by high-pressure liquid chromatography, and the filler is Kromasil C18 filler. Elution with 40% volume concentration of acetonitrile in water gave a purity of 95.68%.
步骤7:步骤6中的洗脱液用乙酸乙酯进行萃取,静置分液得到有机相。有机相用无水硫酸镁进行脱水、过滤。脱水后的有机相,在40℃条件下,用旋转蒸发器浓缩至固体粉末,纯度为95.66%,总收率为25.1%。Step 7: The eluate in step 6 was extracted with ethyl acetate, and left to separate liquids to obtain an organic phase. The organic phase was dehydrated with anhydrous magnesium sulfate and filtered. The dehydrated organic phase was concentrated to a solid powder with a rotary evaporator at 40° C., with a purity of 95.66% and a total yield of 25.1%.
实施例10:Example 10:
步骤1:取25L的FR901464发酵液,加入2kg大孔树脂HZ818,搅拌8h后,取样检测发酵液中FR901464含量为126ug/ml。然后用振荡筛分离发酵液和大孔树脂,得到1.8kg大孔树脂HZ818。Step 1: Take 25L of FR901464 fermentation broth, add 2kg of macroporous resin HZ818, stir for 8 hours, take a sample to detect that the content of FR901464 in the fermentation broth is 126ug/ml. Then, separate the fermented liquid and the macroporous resin with a vibrating sieve to obtain 1.8 kg of macroporous resin HZ818.
步骤2:在1.8kg大孔树脂HZ818中加入3.6L的二氯甲烷浸提,浸提时间2h,浸提两次,得到混合浸提液7.1L。Step 2: Add 3.6 L of dichloromethane to 1.8 kg of macroporous resin HZ818 for leaching. The leaching time is 2 hours, and leaching is performed twice to obtain 7.1 L of mixed extracts.
步骤3:混合浸提液静置分液,得到有机相7L。将有机相在40℃条件下,通过旋转蒸发器进行浓缩,将混合浸提液浓缩至膏状。Step 3: The mixed extracts were left to stand for liquid separation to obtain 7L of organic phase. The organic phase was concentrated by a rotary evaporator at 40° C., and the mixed extract was concentrated to a paste.
步骤4:用正己烷与乙酸乙酯混合溶剂(体积比40:60)溶解膏状物并过滤。滤液用硅胶填料进行色谱分离,得到纯度为52.23%的洗脱液。洗脱液在40℃条件下,通过旋转蒸发器进行浓缩,将洗脱液浓缩至膏状。Step 4: Dissolve the paste with a mixed solvent of n-hexane and ethyl acetate (volume ratio 40:60) and filter. The filtrate was chromatographed with a silica gel packing to obtain an eluate with a purity of 52.23%. The eluate was concentrated by a rotary evaporator at 40° C., and the eluate was concentrated to a paste.
步骤5:重复步骤4得到纯度为68.37%的洗脱液。洗脱液在40℃条件下,通过旋转蒸发器进行浓缩,将洗脱液浓缩至膏状。Step 5: Step 4 was repeated to obtain an eluate with a purity of 68.37%. The eluate was concentrated by a rotary evaporator at 40° C., and the eluate was concentrated to a paste.
步骤6:上述膏状物用30%体积分数的乙腈配制成上柱液。上柱液用高压液相色谱仪进行分离纯化,填料为纳微C18填料。用35%体积浓度的乙腈水溶液进行洗脱,得到纯度为 96.30%。Step 6: The above-mentioned paste is prepared into a column liquid with 30% volume fraction of acetonitrile. The upper column liquid is separated and purified by high-pressure liquid chromatography, and the filler is nano-micro C18 filler. Elution with 35% volume concentration of acetonitrile in water gave a purity of 96.30%.
步骤7:步骤6中的洗脱液用乙酸乙酯进行萃取,静置分液得到有机相。有机相用无水硫酸镁进行脱水、过滤。脱水后的有机相,在40℃条件下,用旋转蒸发器浓缩至固体粉末,纯度为96.02%,总收率为27.2%。Step 7: The eluate in step 6 was extracted with ethyl acetate, and left to separate liquids to obtain an organic phase. The organic phase was dehydrated with anhydrous magnesium sulfate and filtered. The dehydrated organic phase was concentrated to a solid powder with a rotary evaporator at 40° C., with a purity of 96.02% and a total yield of 27.2%.
Claims (10)
- 一种从发酵液提取FR901464的方法,其特征在于:A method for extracting FR901464 from fermentation broth, characterized in that:所述发酵液由伯克霍尔德菌发酵得到,提取方法包括以下步骤:The fermented liquid is fermented by Burkholderia, and the extraction method comprises the following steps:步骤1:将大孔树脂加入发酵液,混合吸附后过滤;Step 1: Add the macroporous resin to the fermentation broth, mix and absorb and filter;步骤2:将过滤得到的大孔树脂用有机溶剂浸泡并分离,将分离后的有机溶剂浓缩;Step 2: Soak and separate the macroporous resin obtained by filtration with an organic solvent, and concentrate the separated organic solvent;步骤3:用混合溶剂溶解步骤2浓缩后的产物,在硅胶柱中分离过滤,经洗脱剂A淋洗得到洗脱液;Step 3: dissolving the product concentrated in step 2 with a mixed solvent, separating and filtering in a silica gel column, and rinsing with eluent A to obtain an eluent;步骤4:浓缩洗脱液至膏状,随后配制成上柱液,并用洗脱剂B经高压液相色谱仪分离纯化。Step 4: Concentrate the eluate to a creamy state, and then make it into a column liquid, and use eluent B to separate and purify by high-pressure liquid chromatography.
- 根据权利要求1所述的方法,其特征在于:The method according to claim 1, characterized in that:所述混合溶剂由极性溶剂和非极性溶剂混合而成。The mixed solvent is formed by mixing polar solvents and non-polar solvents.
- 根据权利要求2所述的方法,其特征在于:The method according to claim 2, characterized in that:所述极性溶剂选自醇、酸、脂、腈、水,优选地选自为异丙醇、正丁醇、四氢呋喃、氯仿、乙醇、乙酸乙酯、甲醇、丙酮、乙腈、乙酸,更优选地为乙酸乙酯;The polar solvent is selected from alcohol, acid, fat, nitrile, water, preferably selected from isopropanol, n-butanol, tetrahydrofuran, chloroform, ethanol, ethyl acetate, methanol, acetone, acetonitrile, acetic acid, more preferably ground is ethyl acetate;所述非极性溶剂选自饱和烃类、苯,优选地为正己烷。The non-polar solvent is selected from saturated hydrocarbons, benzene, preferably n-hexane.
- 根据权利要求3所述的方法,其特征在于:The method according to claim 3, characterized in that:正己烷与乙酸乙酯混合形成所述混合溶剂,其中乙酸乙酯的体积分数不大于70%。The mixed solvent is formed by mixing n-hexane and ethyl acetate, wherein the volume fraction of ethyl acetate is not more than 70%.
- 根据权利要求4所述的方法,其特征在于:The method according to claim 4, characterized in that:步骤4中,用30%体积分数的乙腈配制成上柱液。In step 4, use 30% volume fraction of acetonitrile to prepare the upper column solution.
- 根据权利要求5所述的方法,其特征在于:The method according to claim 5, characterized in that:洗脱剂A为乙酸乙酯,Eluent A is ethyl acetate,洗脱剂B选自乙腈或甲醇的水溶液。Eluent B is selected from acetonitrile or methanol in water.
- 根据权利要求6所述的方法,其特征在于:The method according to claim 6, characterized in that:步骤2中的有机溶剂选自乙酸乙酯、二氯甲烷、氯仿。The organic solvent in step 2 is selected from ethyl acetate, dichloromethane, chloroform.
- 根据权利要求7所述的方法,其特征在于:The method according to claim 7, characterized in that:洗脱剂B为乙腈溶液,体积浓度为30%-45%,或者为30%-40%。The eluent B is an acetonitrile solution with a volume concentration of 30%-45%, or 30%-40%.
- 根据权利要求8所述的方法,其特征在于:The method according to claim 8, characterized in that:步骤4中,上柱液在高压液相色谱仪中的流速为50-70ml/min,优选70ml/min。In step 4, the flow rate of the upper column liquid in the high pressure liquid chromatograph is 50-70ml/min, preferably 70ml/min.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110942764.2A CN113563361B (en) | 2021-08-17 | 2021-08-17 | Method for extracting FR901464 from Burkholderia fermentation broth |
CN202110942764.2 | 2021-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023020501A1 true WO2023020501A1 (en) | 2023-02-23 |
Family
ID=78171983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/112833 WO2023020501A1 (en) | 2021-08-17 | 2022-08-16 | Method for extracting fr901464 from burkholderia fermentation broth |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113563361B (en) |
WO (1) | WO2023020501A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115491319A (en) * | 2021-06-18 | 2022-12-20 | 浙江珲达生物科技有限公司 | Burkholderia and method for producing FR901464 by fermenting Burkholderia |
CN113563361B (en) * | 2021-08-17 | 2022-05-20 | 浙江珲达生物科技有限公司 | Method for extracting FR901464 from Burkholderia fermentation broth |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105829299A (en) * | 2013-11-19 | 2016-08-03 | 普渡研究基金会 | Anti-cancer agents and preparation thereof |
CN111246740A (en) * | 2017-09-08 | 2020-06-05 | 马罗内生物创新公司 | Novel herbicidal compounds |
CN113563361A (en) * | 2021-08-17 | 2021-10-29 | 浙江珲达生物科技有限公司 | Method for extracting FR901464 from Burkholderia fermentation broth |
-
2021
- 2021-08-17 CN CN202110942764.2A patent/CN113563361B/en active Active
-
2022
- 2022-08-16 WO PCT/CN2022/112833 patent/WO2023020501A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105829299A (en) * | 2013-11-19 | 2016-08-03 | 普渡研究基金会 | Anti-cancer agents and preparation thereof |
CN111246740A (en) * | 2017-09-08 | 2020-06-05 | 马罗内生物创新公司 | Novel herbicidal compounds |
CN113563361A (en) * | 2021-08-17 | 2021-10-29 | 浙江珲达生物科技有限公司 | Method for extracting FR901464 from Burkholderia fermentation broth |
Non-Patent Citations (3)
Title |
---|
EUSTAQUIO ALESSANDRA S.; CHANG LI-PING; STEELE GREG L.; O'DONNELL CHRISTOPHER J.; KOEHN FRANK E.: "Biosynthetic engineering and fermentation media development leads to gram-scale production of spliceostatin natural products inBurkholderiasp.", METABOLIC ENGINEERING, ACADEMIC PRESS, AMSTERDAM, NL, vol. 33, 24 November 2015 (2015-11-24), AMSTERDAM, NL, pages 67 - 75, XP029375526, ISSN: 1096-7176, DOI: 10.1016/j.ymben.2015.11.003 * |
HAIYIN HE, ET AL.: "Cytotoxic Spliceostatins from Burkholderia sp. and Their Semisynthetic Analogues", JOURNAL OF NATURAL PRODUCTS, AMERICAN CHEMICAL SOCIETY, US, vol. 77, no. 8, 1 August 2014 (2014-08-01), US , pages 1864 - 1870, XP055451569, ISSN: 0163-3864, DOI: 10.1021/np500342m * |
NAKAJIMA, H.; SATO, B.; FUJITA, T.; TAKASE, S.; TERANO, H.; OKUHARA, M.: "New antitumor substances FR901463, FR901464 and FR901465. I. Taxonomy, Fermentation, Isolation, Physico-chemical properties and biological activities", THE JOURNAL OF ANTIBIOTICS, NATURE PUBLISHING GROUP UK, LONDON, vol. 49, no. 12, 1 January 1996 (1996-01-01), London, pages 1196 - 1203, XP009169158, ISSN: 0021-8820, DOI: 10.7164/antibiotics.49.1196 * |
Also Published As
Publication number | Publication date |
---|---|
CN113563361B (en) | 2022-05-20 |
CN113563361A (en) | 2021-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023020501A1 (en) | Method for extracting fr901464 from burkholderia fermentation broth | |
US6136989A (en) | Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material | |
EP2647643B1 (en) | Procedure for the purification of tiacumicin b | |
JP2019506133A (en) | Improved process for producing fucoxanthin and / or polysaccharides from microalgae | |
JP6592500B2 (en) | Purification method of fidaxomycin | |
CN104844620B (en) | A kind of isolation and purification method of rapamycin | |
CN105585578B (en) | A kind of preparation method of rapamycin | |
CN102372723B (en) | Method for extracting arglabin from artemisia myriantha | |
CN104894173B (en) | A kind of preparation method of curcumin derivate | |
CN110003153B (en) | Benzofuran compound and preparation method and application thereof | |
CN107954839B (en) | Anti-inflammatory active compound peniroquesine A and preparation method and application thereof | |
CN107805188B (en) | Biphenyl compound and preparation method and application thereof | |
CN115109023A (en) | Macrolide compound FWYZ52-A, and fermentation strain, fermentation method and application thereof | |
CN105289545B (en) | A kind of preparation of rapamycin separation adsorbent | |
CN103073624B (en) | A kind of preparation method of high purity cyclosporin A derivative | |
CN109609568B (en) | Method for preparing swainsonine by solid fermentation | |
CN107573362A (en) | A kind of method of the separating-purifying sirolimus from zymotic fluid | |
CN104497079B (en) | The preparation method of high-purity OP-1405 | |
CN107686492A (en) | A kind of method of rhodioside in extraction purification zymotic fluid using macroporous absorbent resin | |
CN112321664A (en) | Method for extracting, separating and purifying inonotus obliquus alcohol | |
CN114875096B (en) | Method for liquid optimized culture and polysaccharide extraction of coprinus comatus | |
CN115433087B (en) | Method for extracting dibutyl terephthalate from Raffaelea lauricola | |
CN115504990B (en) | Sugar-spiro-macrolide compound FW-5-39 and preparation method and application thereof | |
CN107652262B (en) | Preparation method and application of amicumacecin isocoumarin compound | |
CN111285828B (en) | Compound proximicin and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22857812 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22857812 Country of ref document: EP Kind code of ref document: A1 |